We were recently featured in Sports Illustrated. View the full article here: https://www.si.com/nfl/2018/01/03/football-concussion-cte-players-mercaptor-captons-jim-kovach
By TOM TAYLOR January 03, 2018 The more science teaches us about head injury, the more football seems to be doomed. But could science also save football? Might medicine offer us a miracle cure for degenerative brain disease? Since 2008, pathologists at Boston University have been repeatedly raising the alarm about the effects of life […]
Ralph O’Rear provides Mercaptor strategic advice with regards to general business strategy, facilities, and operations. After 18 years at the Buck Institute for Research on Aging and nearly 10 years at Lucasfilm Ltd. and its subsidiaries and affiliates (Industrial Light and Magic, LucasArts Entertainment, THX), Mr. O’Rear began to independently consult with the goal of doing […]
Mercaptor is pursuing non-dilutive funding for preclinical studies in models of stroke, TBI, Seizers, amyotrophic lateral sclerosis, and stroke. Proof-of-concept data will gate additional fundraising efforts. Our goal is to bring drug candidates to the clinical stage in both humans and companion animals.
Sara Isbell has an extensive background in neuroscience, with specific training and expertise in neurodegenerative diseases and conditions, including a recently published paper in drug design and development in Dove Medical Press. Over the course of her 22-year career as she developed novel experiments and consistently contributed to cutting-edge research. This experience was integral to […]
Amanda has been an integral part of our close-knit team for more than 14 years. Her years of industry and academic experience have helped her gain a comprehensive understanding of important concepts and techniques relevant to our research. Her educational experience from her undergraduate and master’s programs includes an emphasis on neurobiology, oncology, and stem […]
Prior to joining Mercaptor Discoveries, Victoria served in Global Medical Affairs, Clinical Development and Research and Discovery with Raptor Pharmaceuticals (acquired by Horizon Pharma). Victoria holds a BS in Biochemistry from the University of the Pacific, an MS in Management with a concentration in Project Management and has an MBA.
Sheana has been with Mercaptor since it was founded in 2017. She has been instrumental in creating processes and structure for the Laboratory and the Organization as a whole. Sheana has spent the last four years in the Laboratory at the bench conducting experiments, serving as the Health and Safety Officer, avidly participating in community […]
Ms. Tsuchimoto co-founded Mercaptor Discoveries Inc. and is our part-time Chief Financial Officer. Ms. Tsuchimoto is also the Chief Financial Officer of Monopar Therapeutics since June 2015. Ms. Tsuchimoto has spent over nine years at Raptor Pharmaceuticals, as its Chief Financial Officer from Raptor’s inception in May 2006 until August 2012, as Raptor’s Vice President […]